Similar articles for PMID: 25993609

Year	Number of Results
1993	1
1999	1
2002	3
2003	8
2004	2
2005	7
2006	5
2007	7
2008	3
2009	14
2010	11
2011	12
2012	18
2013	27
2014	18
2015	32
2016	22
2017	18
2018	14
2019	21
2020	30
2021	34
2022	22
2023	12
2024	0

1

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.

Carruthers J, Rivkin A, Donofrio L, Bertucci V, Somogyi C, Lei X, Davis PG, Campo A, Beddingfield FC. Carruthers J, et al. Dermatol Surg. 2015 Jun;41(6):702-11. doi: 10.1097/DSS.0000000000000357. Dermatol Surg. 2015. PMID: 25993609 Clinical Trial.

2

Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.

Kawashima M, Harii K, Horiuchi Y, Seidman E, Lei X, Hopfinger R, Lee E. Kawashima M, et al. Dermatol Surg. 2020 Apr;46(4):483-490. doi: 10.1097/DSS.0000000000002143. Dermatol Surg. 2020. PMID: 31517663 Clinical Trial.

3

Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial.

Carruthers A, Bruce S, de Coninck A, Connolly S, Cox SE, Davis PG, Campo A, Lei X, Somogyi C, Lee E, McLean H, Beddingfield F. Carruthers A, et al. Dermatol Surg. 2014 Nov;40(11):1181-90. doi: 10.1097/DSS.0000000000000128. Dermatol Surg. 2014. PMID: 25347451 Clinical Trial.

4

Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure.

Rivers JK, Bertucci V, McGillivray W, Muhn C, Rosen N, Solish N, Weichman BM, Wheeler S, Daniels SR, Gallagher CJ. Rivers JK, et al. Dermatol Surg. 2015 Aug;41(8):950-9. doi: 10.1097/DSS.0000000000000424. Dermatol Surg. 2015. PMID: 26218728 Clinical Trial.

5

Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial.

Moers-Carpi M, Carruthers J, Fagien S, Lupo M, Delmar H, Jones D, Somogyi C, Lee E, Lei X, MacKinnon S, Davis PG, Yalamanchili R, Campo A, Beddingfield FC 3rd. Moers-Carpi M, et al. Dermatol Surg. 2015 Jan;41(1):102-12. doi: 10.1097/DSS.0000000000000220. Dermatol Surg. 2015. PMID: 25485803 Clinical Trial.

6

Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials.

Baumann L, Dayan S, Connolly S, Silverberg N, Lei X, Drinkwater A, Gallagher CJ. Baumann L, et al. Dermatol Surg. 2016 May;42(5):598-607. doi: 10.1097/DSS.0000000000000757. Dermatol Surg. 2016. PMID: 27110893 Free PMC article. Clinical Trial.

7

OnabotulinumtoxinA (Botox) in the Treatment of Crow's Feet Lines in Japanese Subjects.

Harii K, Kawashima M, Furuyama N, Lei X, Hopfinger R, Lee E. Harii K, et al. Aesthetic Plast Surg. 2017 Oct;41(5):1186-1197. doi: 10.1007/s00266-017-0844-9. Epub 2017 Jul 21. Aesthetic Plast Surg. 2017. PMID: 28733805 Free PMC article. Clinical Trial.

8

Efficacy and Safety of OnabotulinumtoxinA Treatment of Forehead Lines: A Multicenter, Randomized, Dose-Ranging Controlled Trial.

Solish N, Rivers JK, Humphrey S, Muhn C, Somogyi C, Lei X, Bhogal M, Caulkins C. Solish N, et al. Dermatol Surg. 2016 Mar;42(3):410-9. doi: 10.1097/DSS.0000000000000626. Dermatol Surg. 2016. PMID: 26863598 Clinical Trial.

9

Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.

De Boulle K, Werschler WP, Gold MH, Bruce S, Sattler G, Ogilvie P, Street J, Larsen KE, Yushmanova I, Lei X, Lee E, Vitarella D, Mao C. De Boulle K, et al. Dermatol Surg. 2018 Nov;44(11):1437-1448. doi: 10.1097/DSS.0000000000001612. Dermatol Surg. 2018. PMID: 30096106 Clinical Trial.

10

OnabotulinumtoxinA for Simultaneous Treatment of Upper Facial Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Study.

Rivkin AZ, Ogilvie P, Dayan S, Yoelin SG, Weichman BM, Garcia JK. Rivkin AZ, et al. Dermatol Surg. 2020 Jan;46(1):50-60. doi: 10.1097/DSS.0000000000001883. Dermatol Surg. 2020. PMID: 30829771 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

317 results

Results by year